Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention

Background: Elevated lipoprotein(a) (Lp[a]) is a risk factor for first atherosclerotic thrombosis events, but the role of elevated Lp(a) in secondary prevention is controversial. This study aimed to retrospectively investigate the influence of elevated Lp(a) levels on the prognosis of patients with...

Full description

Saved in:
Bibliographic Details
Main Authors: Azhi ShaMa, MM, Chunlan Ma, BS, Yingying Huang, BS, Jingyue Hu, BS, Chunmei Xu, BS, Zhuxin Li, BS, Jing Wang, MD, PhD, Chunyu Zeng, MD, PhD
Format: Article
Language:English
Published: The Texas Heart Institute 2024-12-01
Series:Texas Heart Institute Journal
Subjects:
Online Access:https://thij.staging.kglmeridian.com/downloadpdf/view/journals/thij/51/2/article-e238372.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846118992260890624
author Azhi ShaMa, MM
Chunlan Ma, BS
Yingying Huang, BS
Jingyue Hu, BS
Chunmei Xu, BS
Zhuxin Li, BS
Jing Wang, MD, PhD
Chunyu Zeng, MD, PhD
author_facet Azhi ShaMa, MM
Chunlan Ma, BS
Yingying Huang, BS
Jingyue Hu, BS
Chunmei Xu, BS
Zhuxin Li, BS
Jing Wang, MD, PhD
Chunyu Zeng, MD, PhD
author_sort Azhi ShaMa, MM
collection DOAJ
description Background: Elevated lipoprotein(a) (Lp[a]) is a risk factor for first atherosclerotic thrombosis events, but the role of elevated Lp(a) in secondary prevention is controversial. This study aimed to retrospectively investigate the influence of elevated Lp(a) levels on the prognosis of patients with coronary artery disease. Methods: The team collected and compared clinical information of patients hospitalized during percutaneous coronary intervention (PCI). This study used a multivariate logistic regression model to evaluate the relationships between Lp(a) levels, cardiovascular risk factors, and the prognosis of coronary artery disease in patients undergoing PCI. Results: There were no statistically significant differences between patients grouped according to Lp(a) level in terms of sex; age; body mass index and obesity; hyperuricemia; smoking; cardiac insufficiency; acute myocardial infarction; multivessel lesion; in-stent restenosis; secondary PCI; apolipoprotein AI level; incidence of high total cholesterol or high low-density lipoprotein cholesterol; or family history of hypertension, diabetes, or coronary artery disease. The average Lp(a) concentration did not statistically significantly decrease after 1 year of statin treatment after PCI. One year after patients began statins, there were no significant differences between Lp(a) groups in the incidence of high triglycerides (P = .13), high total cholesterol (P = .52), or high low-density lipoprotein cholesterol (P = .051). Multivariate logistic regression analysis indicated that diabetes (P = .02) was associated with in-stent restenosis, whereas diabetes (P = .02) and multivessel lesions (P < .001) were associated with secondary PCI in patients who underwent coronary angiography 1 year after PCI. Compared with normal Lp(a) levels, high Lp(a) levels did not significantly increase the incidence of in-stent restenosis or secondary PCI in patients who underwent coronary angiography 1 year after PCI. Conclusion: Sustained high concentrations of Lp(a) did not significantly increase the incidence of in-stent restenosis or secondary PCI in patients who underwent coronary angiography 1 year after PCI.
format Article
id doaj-art-d086aa81f9f14cf1841c593ad0c5e38b
institution Kabale University
issn 1526-6702
language English
publishDate 2024-12-01
publisher The Texas Heart Institute
record_format Article
series Texas Heart Institute Journal
spelling doaj-art-d086aa81f9f14cf1841c593ad0c5e38b2024-12-17T08:03:44ZengThe Texas Heart InstituteTexas Heart Institute Journal1526-67022024-12-015121810.14503/THIJ-23-8372i1526-6702-51-2-e238372Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary InterventionAzhi ShaMa, MM0Chunlan Ma, BS1Yingying Huang, BS2Jingyue Hu, BS3Chunmei Xu, BS4Zhuxin Li, BS5Jing Wang, MD, PhD6Chunyu Zeng, MD, PhD71 Department of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, People's Republic of China1 Department of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, People's Republic of China1 Department of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, People's Republic of China2 Department of Neurology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, People's Republic of China1 Department of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, People's Republic of China1 Department of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, People's Republic of China3 Department of Cardiology, The First Affiliated Hospital of Qunming Medical University, Qunming, Yunnan Province, People's Republic of China1 Department of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, People's Republic of ChinaBackground: Elevated lipoprotein(a) (Lp[a]) is a risk factor for first atherosclerotic thrombosis events, but the role of elevated Lp(a) in secondary prevention is controversial. This study aimed to retrospectively investigate the influence of elevated Lp(a) levels on the prognosis of patients with coronary artery disease. Methods: The team collected and compared clinical information of patients hospitalized during percutaneous coronary intervention (PCI). This study used a multivariate logistic regression model to evaluate the relationships between Lp(a) levels, cardiovascular risk factors, and the prognosis of coronary artery disease in patients undergoing PCI. Results: There were no statistically significant differences between patients grouped according to Lp(a) level in terms of sex; age; body mass index and obesity; hyperuricemia; smoking; cardiac insufficiency; acute myocardial infarction; multivessel lesion; in-stent restenosis; secondary PCI; apolipoprotein AI level; incidence of high total cholesterol or high low-density lipoprotein cholesterol; or family history of hypertension, diabetes, or coronary artery disease. The average Lp(a) concentration did not statistically significantly decrease after 1 year of statin treatment after PCI. One year after patients began statins, there were no significant differences between Lp(a) groups in the incidence of high triglycerides (P = .13), high total cholesterol (P = .52), or high low-density lipoprotein cholesterol (P = .051). Multivariate logistic regression analysis indicated that diabetes (P = .02) was associated with in-stent restenosis, whereas diabetes (P = .02) and multivessel lesions (P < .001) were associated with secondary PCI in patients who underwent coronary angiography 1 year after PCI. Compared with normal Lp(a) levels, high Lp(a) levels did not significantly increase the incidence of in-stent restenosis or secondary PCI in patients who underwent coronary angiography 1 year after PCI. Conclusion: Sustained high concentrations of Lp(a) did not significantly increase the incidence of in-stent restenosis or secondary PCI in patients who underwent coronary angiography 1 year after PCI.https://thij.staging.kglmeridian.com/downloadpdf/view/journals/thij/51/2/article-e238372.pdfcoronary artery diseasecoronary restenosislipoprotein(a)percutaneous coronary intervention
spellingShingle Azhi ShaMa, MM
Chunlan Ma, BS
Yingying Huang, BS
Jingyue Hu, BS
Chunmei Xu, BS
Zhuxin Li, BS
Jing Wang, MD, PhD
Chunyu Zeng, MD, PhD
Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
Texas Heart Institute Journal
coronary artery disease
coronary restenosis
lipoprotein(a)
percutaneous coronary intervention
title Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
title_full Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
title_fullStr Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
title_full_unstemmed Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
title_short Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
title_sort correlation between lipoprotein a and prognosis for coronary artery disease in patients undergoing percutaneous coronary intervention
topic coronary artery disease
coronary restenosis
lipoprotein(a)
percutaneous coronary intervention
url https://thij.staging.kglmeridian.com/downloadpdf/view/journals/thij/51/2/article-e238372.pdf
work_keys_str_mv AT azhishamamm correlationbetweenlipoproteinaandprognosisforcoronaryarterydiseaseinpatientsundergoingpercutaneouscoronaryintervention
AT chunlanmabs correlationbetweenlipoproteinaandprognosisforcoronaryarterydiseaseinpatientsundergoingpercutaneouscoronaryintervention
AT yingyinghuangbs correlationbetweenlipoproteinaandprognosisforcoronaryarterydiseaseinpatientsundergoingpercutaneouscoronaryintervention
AT jingyuehubs correlationbetweenlipoproteinaandprognosisforcoronaryarterydiseaseinpatientsundergoingpercutaneouscoronaryintervention
AT chunmeixubs correlationbetweenlipoproteinaandprognosisforcoronaryarterydiseaseinpatientsundergoingpercutaneouscoronaryintervention
AT zhuxinlibs correlationbetweenlipoproteinaandprognosisforcoronaryarterydiseaseinpatientsundergoingpercutaneouscoronaryintervention
AT jingwangmdphd correlationbetweenlipoproteinaandprognosisforcoronaryarterydiseaseinpatientsundergoingpercutaneouscoronaryintervention
AT chunyuzengmdphd correlationbetweenlipoproteinaandprognosisforcoronaryarterydiseaseinpatientsundergoingpercutaneouscoronaryintervention